These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 12393518

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack.
    Miwa T, Zhou L, Hilliard B, Molina H, Song WC.
    Blood; 2002 May 15; 99(10):3707-16. PubMed ID: 11986227
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Deficiency of decay-accelerating factor and complement receptor 1-related gene/protein y on murine platelets leads to complement-dependent clearance by the macrophage phagocytic receptor CRIg.
    Kim DD, Miwa T, Kimura Y, Schwendener RA, van Lookeren Campagne M, Song WC.
    Blood; 2008 Aug 15; 112(4):1109-19. PubMed ID: 18524992
    [Abstract] [Full Text] [Related]

  • 6. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein.
    Kim YU, Kinoshita T, Molina H, Hourcade D, Seya T, Wagner LM, Holers VM.
    J Exp Med; 1995 Jan 01; 181(1):151-9. PubMed ID: 7528766
    [Abstract] [Full Text] [Related]

  • 7. DAF/Crry double deficiency in mice exacerbates nephrotoxic serum-induced proteinuria despite markedly reduced systemic complement activity.
    Miwa T, Zhou L, Tudoran R, Lambris JD, Madaio MP, Nangaku M, Molina H, Song WC.
    Mol Immunol; 2007 Jan 01; 44(1-3):139-46. PubMed ID: 16887189
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting.
    Sun X, Funk CD, Deng C, Sahu A, Lambris JD, Song WC.
    Proc Natl Acad Sci U S A; 1999 Jan 19; 96(2):628-33. PubMed ID: 9892684
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice.
    Pritchard MT, McMullen MR, Stavitsky AB, Cohen JI, Lin F, Edward Medof M, Nagy LE.
    Gastroenterology; 2007 Mar 19; 132(3):1117-1126. PubMed ID: 17383432
    [Abstract] [Full Text] [Related]

  • 13. Membrane protein Crry maintains homeostasis of the complement system.
    Wu X, Spitzer D, Mao D, Peng SL, Molina H, Atkinson JP.
    J Immunol; 2008 Aug 15; 181(4):2732-40. PubMed ID: 18684964
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Autoantibody-mediated arthritis in the absence of C3 and activating Fcγ receptors: C5 is activated by the coagulation cascade.
    Auger JL, Haasken S, Binstadt BA.
    Arthritis Res Ther; 2012 Dec 13; 14(6):R269. PubMed ID: 23237573
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Complement-dependent enhancement of CD8+ T cell immunity to lymphocytic choriomeningitis virus infection in decay-accelerating factor-deficient mice.
    Fang C, Miwa T, Shen H, Song WC.
    J Immunol; 2007 Sep 01; 179(5):3178-86. PubMed ID: 17709533
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.